Instil Bio, Inc. (TIL) bonds
TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.08−0.16 (-2.56%)
Close on Nov 13, 2026Market cap $41.23MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Instil Bio reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Instil Bio's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Amount issued | Carrying value |
|---|---|---|---|
| 2024 Loan | 6.35% | $85.60M | $85.19M |
| Construction Loan Agreement | – | $85.60M | – |
| Secured Mortgage Loan | 6.35% | $52.10M | $84.81M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?